سعر لنتوجيستون 250مجم/مل حقن عضل امبول 2024

Hydroxyprogesterone caproate 250 mg/ml intramuscular injection (ampoule), a long-acting progestogen.

• Treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV), in non-pregnant women.Population: Non-pregnant womenDailyMed (U.S. National Library of Medicine)
• Management of primary and secondary amenorrhea and of abnormal uterine bleeding due to hormonal imbalance without organic pathology (such as submucous fibroids or uterine cancer), in non-pregnant women.Population: Non-pregnant womenDailyMed (U.S. National Library of Medicine)
• Test for endogenous estrogen production and production of secretory endometrium and desquamation, in non-pregnant women.Population: Non-pregnant womenDailyMed (U.S. National Library of Medicine)

• Serious arterial and venous thromboembolic events (pulmonary embolism, deep vein thrombosis, myocardial infarction, stroke) have been reported with progestins. Other reactions include nausea, vomiting, abdominal cramps or bloating, edema, breakthrough bleeding or spotting, breast tenderness, weight change, headache, migraine, allergic rash, injection-site pain or abscess, cholestatic jaundice, raised blood pressure and depression; coughing, dyspnea and chest constriction have occurred after injection.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known or suspected carcinoma of the breast or other hormone-sensitive cancer, or a history of these; undiagnosed abnormal vaginal bleeding; liver dysfunction or disease; missed abortion; hypersensitivity to the drug or to progestins; use as a diagnostic test for pregnancy; current or past thrombotic or thromboembolic disorders.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Thrombotic and thromboembolic events: stop pending examination if there is sudden partial or complete loss of vision, proptosis, diplopia or migraine; stop if papilledema or retinal vascular lesions are found.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Progestins may decrease glucose tolerance; monitor blood glucose in patients with diabetes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Fluid retention may affect asthma, migraine, epilepsy, or cardiac or renal dysfunction; observe carefully. Observe patients with a history of depression and stop if depression recurs seriously.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• The US label is indicated only in non-pregnant women and lists missed abortion and use as a diagnostic test for pregnancy as contraindications; it gives no guidance on use during pregnancy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Detectable amounts of progestins have been found in the milk of mothers receiving them; many studies have found no adverse effects of progestins on breastfeeding or on infant health, growth or development.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hydroxyprogesterone caproate: Long-acting progestational steroid ester that converts proliferative into secretory endometrium (the US label text says "endothelium"), induces mammary duct development and inhibits gonadotropin production and/or release.